 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 2313-------------------------------------------------- |
|
Pretreating Ocrevus patients w/antihistamines and liquids lowers |
|
infusion reactions by 60% |
|
By: agate Date: December 21, 2018, 11:52 pm |
|
--------------------------------------------------------- |
|
"Pretreating Ocrevus Patients with Multiple Antihistamines and |
|
Liquids Lowers Infusion Reactions by 60%, Study Reports" from |
|
Multiple Sclerosis News Today (December 18, 2018): |
|
https://multiplesclerosisnewstoday.com/2018/12/18/pretreating-ms-patients-with-… |
|
#Post#: 2334-------------------------------------------------- |
|
New premed protocol improves ocrelizumab treatment for MS |
|
By: agate Date: January 3, 2019, 11:09 pm |
|
--------------------------------------------------------- |
|
More on this from MD Magazine, January 3, 2019--"New Premed |
|
Protocol Improves Ocrelizumab Treatment for MS": |
|
https://www.mdmag.com/medical-news/new-premed-protocol-improves-ocrelizumab-tre… |
|
***************************************************** |
